Premature Rupture of Membranes (PROM), defined as the rupture of foetal membranes previous to the onset of hard work, is a commonplace obstetric circumstance that complicates 8 to 10 percent of pregnancies. It’s far divided into the term PROM, happening at or after 37 weeks of gestation, and pre-term PROM (PPROM), occurring earlier than 37 weeks. PPROM money owed for nearly one-0.33 of pre-term births globally, making it a main contributor to neonatal morbidity and mortality. Advances in PROM research have supplied a deeper know-how of its pathophysiological basis and features delivering revolutionary management strategies that purpose to mitigate associated risks.

Understanding the molecular and biochemical changes that lead to PROM has been pivotal in developing targeted interventions. Over the last decade, research has focused on biomarkerdriven diagnostics, regenerative therapies, and microbiome modulation to improve outcomes for both mother and foetus.

Objectives
The review was conducted with following objectives.

1. To evaluate fresh findings about the risk factors and causes of PROM.

2. To discuss emerging treatment strategies and their clinical impact.

3. To explore prevention strategies aiming to reduce the incidence of PROM.

Review of Literature
Several studies have explored the underlying causes of PROM, emphasising factors such as microbial infections, oxidative stress, inflammatory responses, and mechanical stretching of foetal membranes. Xu et al (2023) discussed the molecular mechanisms leading to PROM, including collagen degradation, increased matrix metalloproteinase activity, and inflammatory cytokine release. Garg & Jaiswal (2023) highlighted the role of maternal nutritional deficiencies and environmental factors in PROM occurrence. 

The nitrazine test, ferning test, and sterile speculum inspection are traditional diagnostic techniques for PROM. However, newer, more accurate tests such as amnisure and actim PROM tests have emerged, offering non-invasive, rapid, and reliable detection. Sridhar et al (2025) evaluated the effectiveness of these advanced diagnostic tools in clinical settings, demonstrating improved early detection rates.

Gestational age, infection risk, and foetal health all affect how PROM is managed. Hospital admission, amniocentesis for infection screening, and administration of pre-natal corticosteroids and broad-spectrum antibiotics are common approaches. Recent innovations include hydrogelbased therapies designed to repair ruptured foetal membranes, showing promise for clinical application. Xu et al (2023) explored the potential of tissue engineering and regenerative medicine in membrane healing. PROM is associated with higher risks of chorioamnionitis, placental abruption, and neonatal complications such as cerebral palsy, respiratory distress, and developmental delays. Studies emphasise the importance of preventive strategies, including maternal nutritional support, infection control, and stress management, to reduce PROM recurrence. Garg & Jaiswal (2023) discussed the impact of PROM and the need for improved clinical guidelines. Advances in the understanding and management of premature rupture of membranes is both clinically significant and impactful in the field of maternal and foetal medicine. The choice of this topic was driven by: its clinical importance and high prevalence, impact on maternal and neonatal health, evolving diagnostic tools and management strategies and innovation in foetal membrane biology.

Prevalence and Risk Factors in India
According to studies, 30-40 percent of premature deliveries in India are caused by PROM, which. Complicates around 3 percent of pregnancies. Several factors contribute to PROM in Indian women, including; Infections such as bacterial vaginosis and sexually transmitted diseases; Nutritional deficiencies, particularly low vitamin C and zinc levels; Inadequate pre-natal care due to socioeconomic inequality; Early marriage and teenage pregnancies, which increase the risk of PROM; Limited availability of cutting-edge medical facilities, particularly in remote locations.

Diagnostic and Treatment Advances in India
Indian hospitals and research institutions have made significant strides in diagnosing and managing PROM:

Improved diagnostic tools: Traditional methods like nitrazine tests and sterile speculum examinations are now supplemented with biomarker-based tests such as amnisure and actim PROM, enhancing accuracy.

Antibiotic protocols: Broad-spectrum antibiotics are widely used to prevent chorioamnionitis and neonatal infections. Corticosteroid therapy: Pre-natal corticosteroids are administered to enhance foetal lung maturity, reducing respiratory distress syndrome in pre-term infants.

Neonatal intensive care units (NICUs): The expansion of NICUs across India has improved survival rates for pre-term infants born after PROM.

Challenges in India
Despite advancements, several challenges persist.

• Limited healthcare access in rural areas, leading to delayed diagnosis and treatment.

• High neonatal mortality rates due to inadequate NICU facilities in some regions.

• Variability in clinical guidelines, with differences in PROM management across government and private hospitals.

• Financial constraints, making advanced treatments inaccessible for economically disadvantaged populations.

Future Directions
To improve PROM management in India, experts recommend; Strengthening pre-natal care programmes, especially in rural areas; Enhancing awareness campaigns to educate women about risk factors and preventive measures; Expanding research on regenerative therapies, such as hydrogel-based membrane repair; Standardising clinical guidelines across healthcare institutions to ensure uniform treatment protocols.

Global Scenario on PROM
Around 3 to 10 percent of pregnancies worldwide are affected with PROM, with pre-term PROM being responsible for about one-third of pre-term deliveries (Kumar et al, 2024). Risk factors include: Nutritional deficiencies, particularly low vitamin C and zinc levels; Lifestyle and environmental influences, such as smoking and excessive stress; Genetic predisposition, influencing foetal membrane integrity.

Premature rupture of membranes has garnered global attention due to its impact on maternal and neonatal health. Advances in medical research have led to better understanding of its causes, including genetic predisposition, infections, and environmental factors. Innovative diagnostic techniques, such as improved biochemical markers and imaging methods now allow for earlier and more accurate detection, enabling timely interventions. Treatment approaches have evolved, balancing conservative management with prompt delivery to minimise complications.

New antimicrobial therapies and preventive strategies have contributed to reducing infection risks associated with PROM. Despite these advancements, disparities in healthcare access remain a challenge, especially in resource-limited regions. Continued investment in research, education, and healthcare infrastructure is crucial to further improve outcomes and ensure optimal care for affected individuals worldwide.

Advances in Knowledge about PROM
Pathophysiological Insights

More knowledge regarding the molecular and mobile processes underpinning PROM has been made available by recent studies. Key factors consist of:

Contamination and infection: Microbial invasion of the amniotic sac triggers the discharge of antiinflammatory cytokines, such as interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α), leading to the weakening of foetal membranes.

Matrix metalloproteinases (MMPs): multiplied tiers of MMPs, enzymes involved in extracellular matrix degradation, contribute to membrane rupture.

Oxidative stress: The role of reactive oxygen species (ROS) in Promoting collagen degradation has been highlighted as an essential factor in membrane fragility.

Genetic contributions: Genetic variations in genes encoding structural proteins and anti-inflammatory mediators were connected to PROM susceptibility, paving the way for personalised threat evaluation.

The Microbiome’s Role

Emerging studies underscore the impact of vaginal and placental microbiota on PROM. Membrane weakening has been linked to dysbiosis, an imbalance in microbial populations. Probiotic based healing procedures are being explored as potential preventive measures.

Pathophysiology

Burst of amniotic sac before beginning of labour it is known as PROM puts the mother and foetus at danger. The pathophysiology of PROM includes inflammation, mechanical stress, and enzymatic degradation that weakens the foetal membranes. Membrane fragility is caused by many factors, including infection, apoptosis, and collagen degradation. Premature rupture can affect newborn outcomes by causing issues such as ascending infections, compression of the umbilical cord, and pre-term birth.

The chance of PROM is increased by such as risk factors, as smoking, multiple gestations, maternal infections (such as bacterial vaginosis), and a history of premature delivery or PROM. Membrane vulnerability is also influenced by low body mass index, severe uterine distension, and nutritional deficits. Further, the risk is increased by invasive pre-natal treatments like amniocentesis. Better maternal-foetal health outcomes and the avoidance of PROM-related problems depend on the early detection and treatment of risk factors.

The foetal membranes consist of the amnion and chorion, which are structurally supported by extracellular matrix proteins, including collagen, laminin, and fibronectin. PROM occurs when these components degrade, leading to membrane weakness and rupture.

Key Risk Factors

• Infections: Intrauterine infections such as bacterial vaginosis and Group B Streptococcus (GBS) have been implicated in membrane weakening.

• Inflammation: Increased levels of proinflammatory cytokines, such as IL-6 and TNFalpha, contribute to premature degradation.

• Mechanical tress: Polyhydramnios, multiple gestations, and cervical incompetence increase membrane strain.

• Genetic and epigenetic factors: Variations in extracellular matrix protein genes may predispose individuals to PROM.

The maternal microbiota is a key factor in determining the integrity of the membrane, according to recent research. Disruptions in vaginal and placental microbiota are associated with a higher risk of PPROM, reinforcing the need for microbiome-targetted interventions.

Advances in Diagnostic Techniques Traditional diagnostic methods, such as sterile speculum examination, nitrazine test, and ferning test, have been supplemented with newer, more sensitive approaches:

Biochemicalm arkers

- AmniSure® Test: Detects placental alphamicroglobulin-1 (PAMG-1) with high specificity.

- Actim PROM Test: Identifies insulin-like growth factor-binding protein-1 (IGFBP-1).

- Proteomic profiling: Studies reveal novel markers in vaginal fluid with potential predictive value.

Ultrasound Advancements

- Three-dimensional ultrasound (3D US) provides detailed assessments of membrane thickness.

- Elastography allows for better visualisation of tissue elasticity and early detection of weakening areas.

Point-of-care Diagnostics

- Real-time PROM detection using portable biosensors in environments with limited resources.

Emerging Treatment Approaches

Antibiotic therapy

Antibiotics such as erythromycin and ampicillin remain essential in managing PPROM to prolong pregnancy and minimise infections.

Corticosteroid administration

Antenatal corticosteroids (e.g., betamethasone) significantly reduce neonatal complications like respiratory distress syndrome and intraventricular haemorrhage.

Innovative therapies

Hyaluronic acid applications: Experimental studies suggest hyaluronic acid injections may enhance membrane repair.

Stem cell-based regenerative therapy: Promising findings indicate that amniotic fluid-derived mesenchymal stem cells aid in cellular regeneration.

Targeted cytokine inhibition: Therapies focused on IL-6 and TNF-alpha inhibition may reduce premature membrane degradation. Platelet-rich plasma (PRP): An emerging intervention showing potential in promoting healing.

Preventive Strategies

Progesterone supplementation: Research shows that administering 17α-hydroxyprogesterone corporate during high-risk pregnancies lowers the incidence of PROM.

Nutritional and lifestyle factors

Collagen-supporting nutrients: Zinc, vitamin C, and copper contribute to membrane integrity.

Vaginal probiotics: Use of Lactobacillus-based probiotics demonstrates promise in reducing infection-related PROM.

Microbiome Modulation

Recent research emphasises restoring a healthy vaginal microbiome as a preventive approach. Treatments targetting dysbiosis in pregnant women may significantly impact membrane stability.

Nursing Responsibilities

Nurses play a critical role in the management of PROM, ensuring both maternal and foetal well-being. With advancements in diagnostics, treatment strategies, and neonatal care, nursing responsibilities have evolved to include early detection, infection prevention, patient education, and emotional support.

Early Detection and Assessment

Conduct thorough patient history and physical examination to identify PROM symptoms; Utilise diagnostic tests such as nitrazine test, ferning test, and amnisure for confirmation; Monitor foetal heart rate and maternal vital signs to detect complications.

Infection Prevention and Management

Administer prophylactic antibiotics to prevent chorioamnionitis and neonatal infections; Maintain strict aseptic techniques during examinations and procedures; Educate patients on hygiene practices to reduce infection risks.

Maternal and Foetal Monitoring

Perform regular foetal movement assessments and non-stress tests (NSTs); Observe amniotic fluid levels and any indications of premature labour; Ensure timely administration of prenatal corticosteroids to enhance foetal lung maturity.

Emotional and Psychological Support

Provide counselling and reassurance to reduce maternal anxiety; Educate families on potential outcomes and management strategies; Encourage support groups for women experiencing PROM.

Collaboration with Healthcare Teams

Work closely with obstetricians, neonatologists, and midwives to optimise patient care; Help make decisions on the manner and time of delivery; Make sure patients and healthcare professionals are communicating effectively.

Postpartum and Neonatal Care

Monitor maternal recovery and signs of postpartum infection; Support neonatal care in NICUs, ensuring proper respiratory support; Educate mothers on breastfeeding and new-born care.

Conclusion
The landscape of PROM research continues to evolve with an increased emphasis on biomarkerdriven diagnostics, regenerative therapies, and microbiome-targeted treatments. Clinical management strategies are expected to change as a result of advancements in stem cell treatment and personalised medicine. Further research is required to establish standardised guidelines for novel interventions and to explore gene therapy possibilities for PROM prevention. With continued advancements, the outlook for patients affected by PROM is progressively improving, leading to better maternal and neonatal outcomes.

References

1. Sridhar T, Sudhanshu S, Neeraj H, Elizabeth LV, Swamy VH, Siddhalingayya JH. Clinical implications of premature rupture of membranes in gestational women in a tertiary care hospital: A prospective observational study. Journal of Young Pharmacists 2025; 17(1): 194-200

2. Xu L, Yang T, Wen M, Wen D, Jin C, An M, et al. Frontiers in the etiology and treatment of preterm premature rupture of membranes: From molecular mechanisms to innovative therapeutic strategies. Reproductive Sciences 2023; 31: 917-31

3. Garg A, Jaiswal A. Evaluation and management of premature rupture of membranes: A review article. Cureus (Open Access) 2023; 15(3): e36615. doi: 10.7759/cureus.36615

4. Romero R, et al. Inflammation and premature rupture of membranes: Insights from molecular studies. Am J Obstet Gynecol 2022

5. Siegler Yoav, Weiner Zeev, Solt Ido. ACOG Practice Bulletin No. 217: Prelabor rupture of membranes. Obstet Gynecol 2020 Nov; 136(5): 1061. DOI: 10.1097/AOG.0000000000004142

6. Lee YH, et al. Role of microbiome dysbiosis in premature membrane rupture. J Perinatal Med 2021

7. Singh P, et al. Hyaluronic acid applications in preterm membrane rupture management. Int J Gynecol Obstet 2023

8. Goldenberg RL, et al. Corticosteroids in preterm premature rupture of membranes: A systematic review. Lancet 2021

9. Kumar VN, Sereesha M, Nair A, Deepthi Vishwa. Assessment of maternal and perinatal outcomes in pregnancies with preterm premature rupture of membranes. Int J Med Pharm Res 2024; 5(6): 207-12